Hijacking cancer cells with a virus while blocking cells’ antiviral defenses could knock out mesothelioma
Sbarro Health Research Organization (SHRO)A study exploring a new combination of therapeutic agents has recently been published in the International Journal of Molecular Sciences, describing dl922-947, an oncolytic adenovirus, and AZD1775, an inhibitor of the DNA damage checkpoint kinase WEE1, and their possible efficacy to treat MPM.